Diabetes drug tied to reduced breast cancer risk

NEW YORK (Reuters Health) – Women who have used the diabetes drug metformin for more than five years may have a lower risk of breast cancer than diabetic women on other treatments, a new study finds…

Researchers at Harvard University are currently developing a large clinical trial to test whether using metformin after standard treatment for early breast cancer helps prevent cancer recurrence…

Read more here